ABFM KSA DIABETES FINAL PAPER 2026
COMPLETE QUESTIONS CORRECT
ANSWERS WRITTEN SOLUTION
⩥ What is the time-in-range goal for patients with diabetes using CGM?
Answer: The time-in-range goal is 70% for most patients with diabetes.
⩥ What is the purpose of blood glucose monitoring (BGM)? Answer: To
help patients understand their glucose levels on a day-to-day basis.
⩥ What are the recommended preprandial glucose levels for diabetes
patients? Answer: 80 to 130 mg/dL.
⩥ What peak postprandial glucose level should be maintained after
meals? Answer: Less than 180 mg/dL.
⩥ What are some risk factors for developing type 2 diabetes mellitus?
Answer: Gestational diabetes mellitus, glucose intolerance during
pregnancy, and obesity.
⩥ What is the significance of reporting ulcers or open areas in diabetes
management? Answer: Prompt reporting is crucial for preventing
complications and infections.
, ⩥ What factors should be assessed in a patient with suspected diabetes?
Answer: History of risk factors and symptoms, weight changes, and
recent infections.
⩥ What is the role of regular follow-up with a primary healthcare
provider (PHCP) in diabetes management? Answer: To monitor and
manage blood glucose levels and prevent complications.
⩥ What are the priority collaborative problems for patients with diabetes
mellitus (DM)? Answer: Potential for injury, surgical complications,
kidney disease, and acute complications.
⩥ What is a common drug therapy for lowering blood glucose that
inhibits liver glucose production? Answer: Biguanides, such as
Metformin.
⩥ What should be avoided when taking Metformin? Answer: Alcohol,
due to the risk of lactic acidosis.
⩥ What are Incretin Mimetics (GLP-1 Agonists) used for? Answer: They
work with insulin to lower blood glucose levels and reduce pancreatic
glucagon secretion.
⩥ What is a risk associated with Incretin Mimetics? Answer:
Pancreatitis; report persistent abdominal pain and nausea.
COMPLETE QUESTIONS CORRECT
ANSWERS WRITTEN SOLUTION
⩥ What is the time-in-range goal for patients with diabetes using CGM?
Answer: The time-in-range goal is 70% for most patients with diabetes.
⩥ What is the purpose of blood glucose monitoring (BGM)? Answer: To
help patients understand their glucose levels on a day-to-day basis.
⩥ What are the recommended preprandial glucose levels for diabetes
patients? Answer: 80 to 130 mg/dL.
⩥ What peak postprandial glucose level should be maintained after
meals? Answer: Less than 180 mg/dL.
⩥ What are some risk factors for developing type 2 diabetes mellitus?
Answer: Gestational diabetes mellitus, glucose intolerance during
pregnancy, and obesity.
⩥ What is the significance of reporting ulcers or open areas in diabetes
management? Answer: Prompt reporting is crucial for preventing
complications and infections.
, ⩥ What factors should be assessed in a patient with suspected diabetes?
Answer: History of risk factors and symptoms, weight changes, and
recent infections.
⩥ What is the role of regular follow-up with a primary healthcare
provider (PHCP) in diabetes management? Answer: To monitor and
manage blood glucose levels and prevent complications.
⩥ What are the priority collaborative problems for patients with diabetes
mellitus (DM)? Answer: Potential for injury, surgical complications,
kidney disease, and acute complications.
⩥ What is a common drug therapy for lowering blood glucose that
inhibits liver glucose production? Answer: Biguanides, such as
Metformin.
⩥ What should be avoided when taking Metformin? Answer: Alcohol,
due to the risk of lactic acidosis.
⩥ What are Incretin Mimetics (GLP-1 Agonists) used for? Answer: They
work with insulin to lower blood glucose levels and reduce pancreatic
glucagon secretion.
⩥ What is a risk associated with Incretin Mimetics? Answer:
Pancreatitis; report persistent abdominal pain and nausea.
